US Broker Ratings

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 29% Upside with a Robust Dividend Yield

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the global healthcare sector, commands attention with its rich history dating back to 1781. Headquartered in Chuo, Japan, Takeda has carved..

Stryker Corporation (SYK) Stock Analysis: Exploring a 16.26% Potential Upside in the Medical Devices Sector

Stryker Corporation (NYSE: SYK) stands as a formidable player in the healthcare sector, particularly within the medical devices industry. With a significant market capitalization of $127.55 billion, Stryker is a..

Thermo Fisher Scientific Inc (TMO)

⚠️ No article content returned.

..

Eli Lilly (LLY) Stock Analysis: A Trillion-Dollar Giant with Robust Revenue Growth and Strong Buy Ratings

Eli Lilly and Company (NYSE: LLY) stands tall as a formidable player in the healthcare sector, specifically within the drug manufacturers industry. With a staggering market capitalization of $1.08 trillion,..

Cencora, Inc. (COR) Stock Analysis: Evaluating the 22.67% Upside Potential in Healthcare Distribution

Cencora, Inc. (NYSE: COR), a prominent player in the medical distribution industry, presents a compelling investment opportunity for those eyeing the healthcare sector. Formerly known as AmerisourceBergen Corporation, Cencora has..

Pfizer, Inc. (PFE) Stock Analysis: Exploring a Potential 20% Upside Amidst Strong Dividend Yield

Pfizer, Inc. (NYSE: PFE) remains a prominent player in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $138.44 billion, the company is a heavyweight..

AbbVie Inc. (ABBV) Stock Analysis: Navigating a $447.62 Billion Market Cap with Solid Growth and Dividends

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, continues to capture investor attention with its robust market cap of $447.62 billion. As a research-based biopharmaceutical company, AbbVie engages..

Abbott Laboratories (ABT) Stock Analysis: Potential 23.82% Upside Amid Strong Buy Ratings

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, remains a compelling investment opportunity for individual investors seeking exposure to the dynamic medical devices industry. With a commanding market..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring the 111.90% Potential Upside for Investors

Investors seeking opportunities in the biotech sector might want to turn their attention to Vaxcyte, Inc. (PCVX), a clinical-stage vaccine innovation company that is making strides in the prevention and..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Navigating the Biotech Sector with a Strong Free Cash Flow

Soleno Therapeutics, Inc. (SLNO), a biopharmaceutical company specializing in the development of novel therapeutics for rare diseases, has been capturing investor interest despite a neutral stock performance outlook. With a..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Unveiling a 70.98% Potential Upside for Astute Investors

Investors have their eyes set on iRhythm Holdings, Inc. (IRTC), as the digital healthcare company continues to serve as a pivotal player in the medical devices industry. Specializing in ambulatory..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Unlocking a 25.5% Upside in the Biotech Sector

Sarepta Therapeutics, Inc. (SRPT), a prominent player in the biotechnology industry, is capturing the attention of investors with its innovative approach to treating rare diseases. As a commercial-stage biopharmaceutical company,..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Exploring a 32.9% Potential Upside in Biotechnology

Cytokinetics, Incorporated (NASDAQ: CYTK) stands out in the biotechnology sector with a compelling narrative for investors. With a current market capitalization of $10.7 billion, the company is making waves in..

Waystar Holding Corp. (WAY)

⚠️ No article content returned.

..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Navigating Biotech Opportunities with 24.22% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV) is a prominent player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $22.61 billion, this UK-based company is making..

TransMedics Group, Inc. (TMDX): Investor Outlook on a Healthcare Game Changer with 48.92% Upside Potential

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector, particularly in the niche of organ transplant technology. With a market capitalization of $2.72 billion, this U.S.-based medical..

Prestige Consumer Healthcare (PBH) Stock Analysis: Is a 42% Upside Within Reach?

Prestige Consumer Healthcare Inc. (NYSE: PBH) offers a compelling case for investors seeking potential upside in the healthcare sector. With a market capitalization of $2.23 billion, this Tarrytown, New York-based..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unpacking a 60% Upside Potential

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a stalwart in the biotechnology sector, presents a compelling investment opportunity, with analysts forecasting a potential upside of 60.63%. With its primary focus on developing..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Strong Buy Ratings and 33% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector, is drawing considerable attention from investors with its robust growth prospects and a compelling analyst outlook. With..

RadNet, Inc. (RDNT) Stock Analysis: A 67% Potential Upside Beckons Investors Amid Healthcare Growth

RadNet, Inc. (NASDAQ: RDNT) stands at the forefront of the healthcare sector, specifically in the Diagnostics & Research industry. Based in Los Angeles, California, RadNet is a leading provider of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds